cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Certara Inc
6 own
4 watching
Current Price
$17.62
$0.46
(2.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,895.22M
52-Week High
52-Week High
24.96000
52-Week Low
52-Week Low
11.81000
Average Volume
Average Volume
0.28M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,895.22M
icon52-Week High24.96000
icon52-Week Low11.81000
iconAverage Volume0.28M
iconDividend Yield--
iconP/E Ratio--
What does the Certara Inc do?
We accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. Biosimulation is a powerful technology used to conduct virtual trials using virtual patients to predict how drugs behave in different individuals. Biopharmaceutical companies use our proprietary biosimulation software throughout drug discovery and development to inform critical decisions that not only save significant time and money but also advance drug safety and efficacy, improving millions of lives each year. --- Certara, Inc. was incorporated in Delaware on June 27, 2017. Our principal executive offices are located at 100 Overlook Center, Suite 101, Princeton, New Jersey 08540. Our telephone number is (609) 716-7900. Our website address is www.certara.com.
Read More
How much money does Certara Inc make?
News & Events about Certara Inc.
Zolmax
9 months ago
Certara, Inc. (NASDAQ:CERT Get Rating) insider Patrick F. Smith sold 19,104 shares of the companys stock in a transaction on Monday, June 5th. The shares were sold at an average price of $21.55, for a total value of $411,691.20. Following the completion of the sale, the insider now directly owns 59,...
TipRanks Financial Blog
9 months ago
Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Certara (CERT Research Report) yesterday and set a price target of $... Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Certara (CERT &#8211...
Globe Newswire
1 year ago
New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses.PRINCETON, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, is adding deep learning ...
Zolmax
1 year ago
Shares of Certara, Inc. (NASDAQ:CERT Get Rating) have received an average recommendation of Moderate Buy from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the ...
Globe Newswire
1 year ago
Certara improves software capabilities by expanding into deep learning and data fabricPRINCETON, N.J., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT),today announced it hasacquiredVyasaAnalytics, LLC. Vyasaprovides scalable deep-learning software whichallowslife sciences ...
Frequently Asked Questions
Frequently Asked Questions
What is Certara Inc share price today?
plus_minus_icon
Can Indians buy Certara Inc shares?
plus_minus_icon
How can I buy Certara Inc shares from India?
plus_minus_icon
Can Fractional shares of Certara Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Certara Inc stocks?
plus_minus_icon
What is today’s traded volume of Certara Inc?
plus_minus_icon
What is today’s market capitalisation of Certara Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Certara Inc?
plus_minus_icon
What percentage is Certara Inc down from its 52-Week High?
plus_minus_icon
What percentage is Certara Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$17.62
$0.46
(2.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00